Octilia Allergia E Infiammazione (Pheniramine Maleate, Tetryzoline Hydrochloride)

Pheniramine Maleate, the active ingredient in Octilia Allergia E Infiammazione, is an antihistamine presented as a tablet for oral use. It treats allergic rhinitis, urticaria and other histamine‑mediated skin and nasal symptoms in adults and children. GNH USA supplies Octilia Allergia E Infiammazione as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Octilia Allergia E Infiammazione as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Octilia Allergia E Infiammazione contains pheniramine maleate, an antihistamine that acts on histamine‑driven allergic pathways. - Allergic rhinitis: reduces nasal congestion, itching and sneezing. - Acute urticaria: alleviates hives and itching. - Seasonal allergy symptoms: provides relief from eye and throat irritation associated with pollen exposure.

Pheniramine maleate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Drowsiness: mild to moderate sedation. - Dry mouth: reduced salivary flow. - Dizziness: transient light‑headedness. - Nausea: occasional stomach upset. - Blurred vision: temporary visual changes. - Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heartbeat. - Severe hypotension: marked drop in blood pressure. - Anaphylaxis: rare systemic allergic reaction. - Hepatic dysfunction: elevated liver enzymes. - Neuroleptic malignant‑like syndrome: rare extrapyramidal signs. - Blood dyscrasias: unexplained bruising or bleeding.

When using pheniramine maleate, consider the following safety measures: - Pregnancy: avoid use unless clearly needed and prescribed. - Breastfeeding: assess risk‑benefit before use. - Elderly patients: start with lower dose and monitor sedation. - Concomitant CNS depressants: avoid additive drowsiness. - Driving or operating machinery: caution due to possible sedation. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Pheniramine maleate can interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other antihistamines: heightened sedation and anticholinergic load. - CNS depressants (benzodiazepines, opioids): amplified central nervous system depression.

Moderate Interactions (Monitor Closely): - Alcohol: increased drowsiness. - Anticholinergic drugs (e.g., atropine): additive dry‑mouth effects. - CYP450 inhibitors (e.g., erythromycin): possible increased pheniramine levels.